The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great. Well, thanks, David, for the presentation. Maybe to start off, big topic right now for a lot of companies is supply chain. Can you just discuss
maybe what the current state of your supply chain is, what some of the challenges have been and then ways that you are mitigating some of that
impact?
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great, thanks. So recently, you made a management announcement regarding the appointment of a Chief Innovation and Technical Officer. Just
wanted to ask strategically what drove that choice and how do you see that role evolving at Standex?
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great. So then maybe a question on the -- your broader portfolio businesses here, just if you can discuss your current outlook or how the M&A
environment is doing. Are there opportunities lined up and how may be that fits into your capital allocation philosophy with leverage below target
like the slide showed?
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great. And then I think another large broad topic would be the infrastructure bill. What impact do you see on some of your end markets or even
your customers' demand for your products in light of that infrastructure bill?
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great. So I think in this presentation and even in the Q&A, you have referenced a lot of upcoming opportunities that are in play for the business.
Specifically on the blood bank and plasma storage opportunity, is there a way to frame the addressable market there on what investors can expect?
And maybe related to that, just on vaccine storage, you mentioned the vaccine rollout having an impact on your business. Are there broader
applications of that type of product or technology going forward for you?
Question: Kevin Condon - Robert W. Baird & Co. - Analyst
: Great. Well, we are butting up against time here for the session. So, David and team at Standex, just wanted to thank you again for joining us. And
thanks to everyone in the audience out there on the line. We hope you had a productive conference and a great day. So, David, thank you again.
| 
